Dengue fever is a mosquito-borne viral infection prevalent in tropical and subtropical regions, primarily transmitted by the Aedes aegypti mosquito. The disease manifests with a wide range of symptoms, including high fever, severe headache, pain behind the eyes, joint and muscle pain, rash, and mild bleeding such as nosebleeds, gum bleeding, or easy bruising. In severe cases, dengue can lead to dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS), which can be fatal if not promptly treated.

Prevention of dengue fever primarily revolves around mosquito control measures and personal protection against mosquito bites. This includes eliminating mosquito breeding sites by emptying stagnant water containers, using mosquito repellents, wearing long-sleeved clothing, and installing window screens and bed nets.

Treatment for dengue fever focuses on supportive care to alleviate symptoms and prevent complications. Patients are advised to stay hydrated, rest, and take acetaminophen for fever and pain relief. However, non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin should be avoided as they can increase the risk of bleeding. In severe cases, hospitalization may be necessary for intravenous fluids and monitoring.

Efforts to develop a dengue vaccine have been ongoing, with some vaccines showing promise in clinical trials. However, challenges remain in developing a vaccine that provides long-lasting immunity against all four dengue virus serotypes.

In conclusion, dengue fever paragraph is a significant public health concern in regions where the Aedes mosquito is prevalent. Prevention efforts focus on mosquito control and personal protection, while treatment involves supportive care. Continued research into vaccines and improved vector control methods is essential to mitigate the impact of this disease on global health.